Arina J Ten Cate-Hoek
Overview
Explore the profile of Arina J Ten Cate-Hoek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
702
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iding A, Ten Cate V, Ten Cate H, Wild P, Ten Cate-Hoek A
Blood Adv
. 2025 Mar;
PMID: 40086064
Post-thrombotic syndrome (PTS) is a heterogenous chronic condition that can develop after deep vein thrombosis (DVT) and is diagnosed using the Villalta scale. This study applied unsupervised machine learning to...
2.
Hupperetz R, Iding A, van Laanen J, Brans R, Notten P, Tick L, et al.
J Thromb Haemost
. 2024 Sep;
22(12):3552-3561.
PMID: 39299612
Background: Adjunctive catheter-directed thrombolysis shows variable efficacy in preventing postthrombotic syndrome (PTS), despite restored patency. Objectives: This Ultrasound-Accelerated Catheter-Directed Thrombolysis Versus Anticoagulation for the Prevention of Post-Thrombotic Syndrome (CAVA) trial...
3.
Iding A, Alkarithi G, Ten Cate H, Ariens R, Ten Cate-Hoek A
Blood Adv
. 2024 Mar;
8(11):2924-2932.
PMID: 38547453
Ultrasound-accelerated catheter-directed thrombolysis (UA-CDT) to improve patency after deep vein thrombosis (DVT) has not conclusively been shown to prevent postthrombotic syndrome (PTS) but might benefit patients who are unlikely to...
4.
Iding A, Limpens T, Ten Cate H, Ten Cate-Hoek A
Eur J Intern Med
. 2023 Oct;
120:85-91.
PMID: 37852838
Background: Clinical management of patients with deep vein thrombosis (DVT) is centered around their risk of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome (PTS). While chronic inflammatory disease (CID) has...
5.
de Jong C, Visser C, Bemelmans R, Boersma W, van den Borst B, Burggraaf J, et al.
Eur Respir J
. 2023 Apr;
61(4).
PMID: 37080574
No abstract available.
6.
Schreurs R, Ten Cate-Hoek A, Ten Cate H, Joore M
Pharmacoecon Open
. 2023 Apr;
7(3):479-491.
PMID: 37074590
Background And Objective: Compression therapy following deep venous thrombosis in the Netherlands is suboptimal. We assessed the budget impact of targeted care improvements. Methods: We calculated the per-patient and population...
7.
Nagy M, Pallares Robles A, Visser M, Koeck T, Ten Cate V, Ten Cate-Hoek A, et al.
J Thromb Haemost
. 2023 Apr;
21(6):1610-1622.
PMID: 37003466
Background: Venous thromboembolism (VTE) is associated with excessive coagulation activity, which in part can be attributed to activation of contact system. However, the knowledge regarding the impact of contact activation...
8.
Iding A, Kremers B, Pallares Robles A, Ten Cate H, Ten Cate-Hoek A
Thromb Haemost
. 2023 Mar;
123(8):763-772.
PMID: 36944356
Background: Residual venous obstruction (RVO) is considered a risk factor of recurrence and possibly other clinical outcomes following deep vein thrombosis (DVT). Current guidelines do not support an RVO-tailored duration...
9.
Akbulut A, Arisz R, Baaten C, Baidildinova G, Barakzie A, Bauersachs R, et al.
Thromb Haemost
. 2023 Mar;
123(8):808-839.
PMID: 36913975
The Fourth Maastricht Consensus Conference on Thrombosis included the following themes. Theme 1: The "coagulome" as a critical driver of cardiovascular disease. Blood coagulation proteins also play divergent roles in...
10.
Iding A, Pallares Robles A, Ten Cate V, Ten Cate H, Wild P, Ten Cate-Hoek A
J Thromb Haemost
. 2023 Feb;
21(5):1238-1247.
PMID: 36736833
Background: Deep vein thrombosis (DVT) is a multifactorial disease with several outcomes, but current classifications solely stratify it based on recurrence risk. Objectives: We aimed to identify DVT phenotypes and...